Biocon shares gain after partner wins insulin contracts worth 225 million Ringgit in Malaysia

Biocon has been working with Duopharma Biotech since 2016 to address Malaysia’s growing diabetes burden. The collaboration has supported more than 4.5 lakh patients so far.

Leave a Reply

Your email address will not be published. Required fields are marked *